BioScan AI utilizes artificial intelligence to analyze retinal images for the early detection of systemic diseases such as Chronic Kidney Disease, Diabetic Retinopathy, and Breast Cancer, providing results in under 60 seconds. The platform offers a non-invasive screening solution that enhances accessibility and reduces the need for on-site eye care specialists, making timely health assessments more efficient and affordable.
Funding
Funding not disclosed
Founders
Product
Problem
Early detection of systemic diseases often requires multiple specialized tests, leading to delays in diagnosis and increased healthcare costs. Traditional diagnostic methods can be invasive, time-consuming, and require specialized personnel, limiting accessibility, particularly in rural areas.
Solution
BioScan AI offers a platform that utilizes artificial intelligence to analyze retinal images and thermal scans for the early detection of multiple systemic diseases, including Diabetic Retinopathy, Chronic Kidney Disease, Cardiovascular Diseases, Alzheimer's, and Breast Cancer. The platform provides rapid results, typically within 60 seconds, enabling timely intervention and improved patient outcomes. BioScan AI's solutions include both the Drishti AI, which analyzes retinal images, and AutoThermix, which uses thermal imaging for breast cancer detection. The company's technology aims to enhance accessibility to health screenings by reducing the need for on-site specialists and offering non-invasive testing methods.
Target Audience
The primary target audience includes healthcare providers, diagnostic clinics, and hospitals seeking to improve early disease detection and offer accessible, non-invasive screening solutions to their patients.
Features
- AI-powered analysis of retinal images for the detection of Glaucoma, Diabetic Macular Edema (DME), Diabetic Retinopathy, and Cardiovascular Diseases (CVD) using Drishti AI.
- Thermal imaging analysis for early detection of breast cancer using AutoThermix.
- Rapid report generation in under 60 seconds, delivered directly to the doctor's registered email.
- Non-invasive and painless testing processes.
- Compatible with various camera models for flexibility and accessibility.
- User-friendly interfaces requiring minimal training.
- Solutions deployable in rural areas without specialized infrastructure.